Lauren Campisano, PA
Medical · Toms River, NJNPI 1104316934
Payments from drug & device makers
Across 181 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$572
- Sanofi$529
- AbbVie$340
- Amgen$312
- Incyte Corporation$205
- Regeneron Healthcare Solutions, Inc.$203
- plus $2K from 16 others
What the payments were for
- Food & beverage$3,44194%
- Education$2356%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 32 | $572 |
| Sanofi | 18 | $529 |
| AbbVie | 23 | $340 |
| Amgen | 15 | $312 |
| Incyte Corporation | 10 | $205 |
| Regeneron Healthcare Solutions, Inc. | 9 | $203 |
| Arcutis Biotherapeutics, Inc. | 11 | $202 |
| Lilly USA, LLC | 12 | $198 |
| Galderma Laboratories, L.p. | 11 | $196 |
| Pfizer | 6 | $171 |
| Novartis | 6 | $154 |
| Johnson & Johnson | 7 | $105 |
| LEO Pharma Inc. | 5 | $96 |
| EPI Health, LLC | 1 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Almirall LLC | 4 | $60 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $58 |
| UCB, Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
How this compares
$3,676 in reported general payments places this provider in the 80th percentile of 573 medical providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 20 | $4,887 |
| Clobetasol Propionate | 27 | $2,679 |
| Fluorouracil | 36 | $2,188 |
| Ketoconazole | 120 | $1,967 |
| Fluocinonide | 47 | $1,846 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 33 | $911 |
| Triamcinolone Acetonide | 58 | $802 |
| Mometasone Furoate | 37 | $796 |
| ValacyclovirValacyclovir Hcl | 42 | $750 |
| Metronidazole | 13 | $597 |
| Mupirocin | 60 | $448 |
| Nystatin | 22 | $351 |
| Hydrocortisone | 21 | $186 |
| Doxycycline Hyclate | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other medical in Toms River
- Cynthia GelnawToms River$5K
- Alison PietrasBrick$1.2M
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.